American International Group, Inc. Acadia Pharmaceuticals Inc Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$17.79 - $30.86 $3,646 - $6,326	205 Added 0.34%	60,440 $1.12 Million
Q4 2023 Feb 13, 2024	SELL	$20.78 - $31.77 $5,049 - $7,720	-243 Reduced 0.4%	60,235 $1.89 Million
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $44,806 - $71,960	2,150 Added 3.69%	60,478 $1.26 Million
Q2 2023 Aug 04, 2023	BUY	$17.8 - $25.65 $5,375 - $7,746	302 Added 0.52%	58,328 $1.4 Million
Q1 2023 May 12, 2023	BUY	$16.32 - $20.92 $18,849 - $24,162	1,155 Added 2.03%	58,026 $1.09 Million
Q4 2022 Feb 10, 2023	SELL	$14.2 - $18.63 $2,953 - $3,875	-208 Reduced 0.36%	56,871 $905,000
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $11,386 - $14,743	807 Added 1.43%	57,079 $934,000
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $41,007 - $85,797	-3,152 Reduced 5.3%	56,272 $793,000
Q1 2022 May 13, 2022	SELL	$20.94 - $27.5 $87,571 - $115,005	-4,182 Reduced 6.57%	59,424 $1.44 Million
Q4 2021 Feb 11, 2022	SELL	$16.79 - $27.09 $31,968 - $51,579	-1,904 Reduced 2.91%	63,606 $1.49 Million
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $24,569 - $38,566	-1,557 Reduced 2.32%	65,510 $1.09 Million
Q2 2021 Aug 13, 2021	BUY	$19.4 - $27.42 $1.25 Million - $1.77 Million	64,585 Added 2602.14%	67,067 $1.64 Million
Q1 2021 May 07, 2021	SELL	$25.02 - $54.99 $7,405 - $16,277	-296 Reduced 10.66%	2,482 $64,000
Q4 2020 Feb 12, 2021	SELL	$41.04 - $56.79 $4,801 - $6,644	-117 Reduced 4.04%	2,778 $149,000
Q3 2020 Nov 04, 2020	SELL	$36.42 - $57.0 $3,496 - $5,472	-96 Reduced 3.21%	2,895 $119,000
Q2 2020 Aug 12, 2020	SELL	$39.26 - $52.73 $2.5 Million - $3.36 Million	-63,645 Reduced 95.51%	2,991 $145,000
Q1 2020 May 04, 2020	SELL	$31.65 - $46.87 $121,852 - $180,449	-3,850 Reduced 5.46%	66,636 $2.82 Million
Q4 2019 Feb 05, 2020	BUY	$36.21 - $51.4 $143,246 - $203,338	3,956 Added 5.95%	70,486 $3.02 Million
Q3 2019 Nov 08, 2019	SELL	$22.22 - $44.01 $10,287 - $20,376	-463 Reduced 0.69%	66,530 $2.39 Million
Q2 2019 Aug 13, 2019	SELL	$23.32 - $28.12 $121,800 - $146,870	-5,223 Reduced 7.23%	66,993 $1.79 Million
Q1 2019 May 06, 2019	BUY	$16.17 - $27.38 $119,949 - $203,104	7,418 Added 11.45%	72,216 $1.94 Million
Q4 2018 Feb 13, 2019	SELL	$14.32 - $22.92 $7,117 - $11,391	-497 Reduced 0.76%	64,798 $1.05 Million
Q3 2018 Nov 09, 2018	BUY	$13.03 - $21.81 $15,323 - $25,648	1,176 Added 1.83%	65,295 $1.36 Million
Q2 2018 Aug 08, 2018	BUY	$15.07 - $22.34 $932,486 - $1.38 Million	61,877 Added 2759.9%	64,119 $979,000
Q1 2018 May 07, 2018	SELL	$22.47 - $32.33 $1,011 - $1,454	-45 Reduced 1.97%	2,242 $50,000
Q4 2017 Feb 09, 2018	BUY	$26.84 - $39.14 $61,383 - $89,513	2,287	2,287 $69,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account